Cardiff Oncology Statistics

Total Valuation

CRDF has a market cap or net worth of $183.28 million. The enterprise value is $98.43 million.

Market Cap	183.28M
Enterprise Value	98.43M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CRDF has 66.53 million shares outstanding. The number of shares has increased by 18.88% in one year.

Current Share Class	66.53M
Shares Outstanding	66.53M
Shares Change (YoY)	+18.88%
Shares Change (QoQ)	+22.70%
Owned by Insiders (%)	2.01%
Owned by Institutions (%)	39.61%
Float	59.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	240.68
Forward PS	524.39
PB Ratio	2.50
P/TBV Ratio	2.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	167.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.02.

Current Ratio	6.22
Quick Ratio	6.04
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.15% and return on invested capital (ROIC) is -48.20%.

Return on Equity (ROE)	-74.15%
Return on Assets (ROA)	-41.00%
Return on Invested Capital (ROIC)	-48.20%
Return on Capital Employed (ROCE)	-72.85%
Revenue Per Employee	$17,788
Profits Per Employee	-$1.48M
Employee Count	33
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.58% in the last 52 weeks. The beta is 1.80, so CRDF's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	-18.58%
50-Day Moving Average	3.19
200-Day Moving Average	3.15
Relative Strength Index (RSI)	46.30
Average Volume (20 Days)	1,019,378

Short Selling Information

The latest short interest is 17.48 million, so 26.27% of the outstanding shares have been sold short.

Short Interest	17.48M
Short Previous Month	17.34M
Short % of Shares Out	26.27%
Short % of Float	29.22%
Short Ratio (days to cover)	12.08

Income Statement

In the last 12 months, CRDF had revenue of $587,000 and -$48.88 million in losses. Loss per share was -$0.92.

Revenue	587,000
Gross Profit	-38.73M
Operating Income	-52.10M
Pretax Income	-40.86M
Net Income	-48.88M
EBITDA	-51.71M
EBIT	-52.10M
Loss Per Share	-$0.92

Full Income Statement

Balance Sheet

The company has $79.89 million in cash and $1.36 million in debt, giving a net cash position of $78.53 million or $1.18 per share.

Cash & Cash Equivalents	79.89M
Total Debt	1.36M
Net Cash	78.53M
Net Cash Per Share	$1.18
Equity (Book Value)	70.88M
Book Value Per Share	1.07
Working Capital	69.42M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-42.75M
Capital Expenditures	n/a
Free Cash Flow	-42.75M
FCF Per Share	-$0.64

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-8,875.64%
Pretax Margin	-8,322.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.88%
Shareholder Yield	n/a
Earnings Yield	-27.62%
FCF Yield	-24.16%

Analyst Forecast

The average price target for CRDF is $12.25, which is 344.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.25
Price Target Difference	344.65%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	168.02%
EPS Growth Forecast (5Y)	16.48%

Stock Forecasts

Stock Splits

The last stock split was on February 20, 2019. It was a reverse split with a ratio of 0.1666666:1.

Last Split Date	Feb 20, 2019
Split Type	Reverse
Split Ratio	0.1666666:1

Scores

CRDF has an Altman Z-Score of -0.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.04
Piotroski F-Score	3